A Novel Therapeutic Approach for the Elimination of Harmful Bacteria From the Microbiome
Time: 1:45 pm
day: Day 2 - Track A Evening
Details:
- Learn the development of Eligobiotics(r): a new class of phage-derived antimicrobials with unparalleled specificity
- EB003: an Eligobiotic(r) for the treatment of Shiga toxin-producing E.coli
- Eligobiotics(r) as novel Gene Therapy products allowing precise intervention on the microbiome
